GMR | 95% CI | p | |
---|---|---|---|
Sociodemographic characteristics | |||
Age, per year | 1.01 | (1.01–1.01) | < 0.001 |
Sex, male | 1.04 | (0.98–1.11) | 0.205 |
Swiss nationality | 1.14 | (1.07–1.23) | < 0.001 |
Private insurance | 1.17 | (1.07–1.28) | 0.001 |
Transport by EMS | 1.34 | (1.25–1.43) | < 0.001 |
Time and day of admission to ED | |||
Saturday or Sunday admission | 0.97 | (0.91–1.04) | 0.395 |
Night-time admissions | 0.78 | (0.74–0.83) | < 0.001 |
Effective weekendsa | 0.93 | (0.87–0.99) | 0.023 |
Effective days offb | 0.98 | (0.92–1.05) | 0.580 |
Comorbidity | |||
COPD | 1.17 | (1.02–1.34) | 0.026 |
Diabetes | 1.14 | (1.04–1.25) | 0.006 |
Liver disease | 1.16 | (1.03–1.31) | 0.015 |
Dementia | 1.51 | (1.22–1.87) | < 0.001 |
Past myocardial infarction | 1.18 | (1.07–1.29) | < 0.001 |
Malignancy | 1.33 | (1.22–1.44) | < 0.001 |
Peripheral artery disease | 1.18 | (0.99–1.42) | 0.068 |
Chronic kidney disease | 1.21 | (1.03–1.41) | 0.021 |
Cerebrovascular disease | 1.38 | (1.23–1.55) | < 0.001 |
Drug intake | |||
On any antidiabetic | 1.18 | (1.06–1.32) | 0.003 |
On any antithrombotic | 1.35 | (1.27–1.45) | < 0.001 |
On any antihypertensive | 1.31 | (1.22–1.4) | < 0.001 |
On any diuretic | 1.33 | (1.22–1.46) | < 0.001 |
On any antiepileptic | 1.04 | (0.93–1.17) | 0.497 |
On any psycholeptic | 1.15 | (1.02–1.29) | 0.025 |
Consultation characteristic | |||
Triage | |||
Urgent | 1 | (base) | |
Highly-urgent | 1.31 | (1. 22–1.39) | < 0.001 |
Outcomes | |||
Hospitalisation | 1.58 | (1.48–1.67) | < 0.001 |
30 d revisits | 0.97 | (0.88–1.06) | 0.474 |
365 d revisits | 1.01 | (0.95–1.08) | 0.752 |
LOS hospital days | 1.02 | (1.01–1.02) | < 0.001 |
LOS ED hours | 1.1 | (1.09–1.11) | < 0.001 |
ICU admission | 1.55 | (1.39–1.74) | < 0.001 |
In-hospital death | 1.46 | (1.15–1.85) | 0.002 |